Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy., Proceedings of the National Academy of Sciences, vol.93, issue.9, pp.4102-4107, 1996. ,
DOI : 10.1073/pnas.93.9.4102
Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy, European Journal of Immunology, vol.158, issue.7, pp.2007-2115, 2001. ,
DOI : 10.1002/1521-4141(200107)31:7<2007::AID-IMMU2007>3.0.CO;2-S
Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding, Nat Med, vol.6, pp.707-710, 2000. ,
Adoptive immunotherapy for cancer: building on success, Nature Reviews Immunology, vol.115, issue.5, pp.383-393, 2006. ,
DOI : 10.1038/nri1842
Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: Cytotoxic activity and T cell receptor gene rearrangements, European Journal of Immunology, vol.1, issue.4, pp.825-831, 1990. ,
DOI : 10.1002/eji.1830200417
High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells, Clin Cancer Res, vol.6, pp.1459-1467, 2000. ,
Programming CD8+ T cells for effective immunotherapy, Current Opinion in Immunology, vol.18, issue.3, pp.363-370, 2006. ,
DOI : 10.1016/j.coi.2006.03.009
High-Fold Expansion of Human Cytotoxic T-Lymphocytes Specific for Autologous Melanoma Cells for Use in Immunotherapy, Journal of Immunotherapy, vol.10, issue.6, pp.405-411, 1991. ,
DOI : 10.1097/00002371-199112000-00003
Detection of intracellular cytokines by flow cytometry, Journal of Immunological Methods, vol.159, issue.1-2, pp.197-207, 1993. ,
DOI : 10.1016/0022-1759(93)90158-4
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients, Cancer Immunology, Immunotherapy, vol.51, issue.10, pp.532-538, 2002. ,
DOI : 10.1007/s00262-002-0313-3
Frequency and relative fraction of tumor antigen-specific T cells among lymphocytes from melanoma-invaded lymph nodes, International Journal of Cancer, vol.18, issue.2, pp.209-215, 1998. ,
DOI : 10.1002/(SICI)1097-0215(19981005)78:2<209::AID-IJC15>3.0.CO;2-5
T Cells for the Treatment of Patients With Metastatic Melanoma, Journal of Clinical Oncology, vol.24, issue.31, pp.5060-5069, 2006. ,
DOI : 10.1200/JCO.2006.07.1100
Large and Dissimilar Repertoire of Melan-A/MART-1-Specific CTL in Metastatic Lesions and Blood of a Melanoma Patient, The Journal of Immunology, vol.169, issue.7, pp.4017-4024, 2002. ,
DOI : 10.4049/jimmunol.169.7.4017
Survival and Tumor Localization of Adoptively Transferred Melan-A-Specific T Cells in Melanoma Patients, The Journal of Immunology, vol.170, issue.4, pp.2161-2169, 2003. ,
DOI : 10.4049/jimmunol.170.4.2161
Mechanisms Regulating the Proliferative Potential of Human CD8+ T Lymphocytes Overexpressing Telomerase, The Journal of Immunology, vol.177, issue.6, pp.3657-3668, 2006. ,
DOI : 10.4049/jimmunol.177.6.3657
Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens, Journal of Immunological Methods, vol.320, issue.1-2, pp.119-131, 2007. ,
DOI : 10.1016/j.jim.2007.01.001
Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma, J Immunol, vol.159, pp.2366-2374, 1997. ,
Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials, Journal of Immunological Methods, vol.102, issue.1, pp.127-141, 1987. ,
DOI : 10.1016/S0022-1759(87)80018-2
Tetramer-Guided Analysis of TCR ??-Chain Usage Reveals a Large Repertoire of Melan-A-Specific CD8+ T Cells in Melanoma Patients, The Journal of Immunology, vol.165, issue.1, pp.533-538, 2000. ,
DOI : 10.4049/jimmunol.165.1.533
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues, J Immunol, vol.160, pp.1750-1758, 1998. ,
Adoptive Transfer of Tumor-Reactive Melan-A-Specific CTL Clones in Melanoma Patients Is Followed by Increased Frequencies of Additional Melan-A-Specific T Cells, The Journal of Immunology, vol.175, issue.7, pp.4797-4805, 2005. ,
DOI : 10.4049/jimmunol.175.7.4797
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells, Proceedings of the National Academy of Sciences, vol.71, issue.2, pp.16168-16173, 2002. ,
DOI : 10.1002/(SICI)1097-0215(19970410)71:2<142::AID-IJC3>3.0.CO;2-0
High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy, J Immunol, vol.162, pp.989-994, 1999. ,